TP53 and neoplasm: In glioblastoma, where alterations in the p53 pathway have been documented [99,100,101,102,103], impairing ongoing tethering of the p53 degradation machinery with the NPC may become an attractive novel approach for reactivating tumor-suppressive function in the p53 protein.